US Stock MarketDetailed Quotes
SYRE Spyre Therapeutics
- 23.860
- +0.730+3.16%
Close Dec 20 16:00 ET
- 23.860
- 0.0000.00%
Post 16:20 ET
1.40BMarket Cap-15.91P/E (TTM)
24.880High22.620Low1.26MVolume22.900Open23.130Pre Close30.17MTurnover2.76%Turnover RatioLossP/E (Static)58.67MShares47.97052wk High8.16P/B1.09BFloat Cap17.83052wk Low--Dividend TTM45.73MShs Float318.750Historical High--Div YieldTTM9.77%Amplitude2.650Historical Low23.922Avg Price1Lot Size
Spyre Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 103.45%414.23M | 81.00%426M | 1,159.53%484.64M | 508.99%339.28M | 508.99%339.28M | 176.34%203.6M | 165.79%235.36M | -42.33%38.48M | -40.18%55.71M | -40.18%55.71M |
| -Cash and cash equivalents | -20.99%71.58M | -80.82%45.14M | 545.67%227.55M | 441.82%188.89M | 441.82%188.89M | 132.35%90.59M | 528.12%235.36M | 140.78%35.24M | 130.24%34.86M | 130.24%34.86M |
| -Short-term investments | 203.21%342.65M | --380.85M | 7,847.11%257.09M | 621.34%150.38M | 621.34%150.38M | 225.79%113.01M | --0 | -93.79%3.24M | -73.27%20.85M | -73.27%20.85M |
| Receivables | ---- | ---- | ---- | --0 | --0 | -75.64%163K | 243.63%1.65M | -67.39%330K | -53.99%375K | -53.99%375K |
| -Other receivables | ---- | ---- | ---- | ---- | ---- | -75.64%163K | 243.63%1.65M | -67.39%330K | -53.99%375K | -53.99%375K |
| Other current assets | 213.31%6.85M | 237.99%9.74M | -52.72%2.63M | -63.53%2.25M | -63.53%2.25M | --2.19M | --2.88M | --5.57M | 24.74%6.17M | 24.74%6.17M |
| Total current assets | 104.46%421.08M | 81.64%435.74M | 998.08%487.27M | 448.57%341.53M | 448.57%341.53M | 150.49%205.95M | 148.21%239.89M | -38.87%44.38M | -37.04%62.26M | -37.04%62.26M |
| Non current assets | ||||||||||
| Net PPE | ---- | ---- | ---- | --0 | --0 | --0 | -69.14%2.32M | -15.81%6.69M | -20.41%6.65M | -20.41%6.65M |
| -Gross PPE | ---- | ---- | ---- | --0 | --0 | --0 | -69.14%2.32M | -15.81%6.69M | -3.25%10.79M | -3.25%10.79M |
| -Accumulated depreciation | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -47.89%-4.14M | -47.89%-4.14M |
| Other non current assets | -99.24%10K | -75.06%331K | -76.30%329K | -85.20%331K | -85.20%331K | -42.23%1.32M | -48.08%1.33M | -47.18%1.39M | -16.57%2.24M | -16.57%2.24M |
| Total non current assets | -99.24%10K | -90.91%331K | -95.93%329K | -96.28%331K | -96.28%331K | -85.92%1.32M | -63.79%3.64M | -23.61%8.08M | -19.47%8.89M | -19.47%8.89M |
| Total assets | 103.16%421.09M | 79.06%436.07M | 829.60%487.6M | 380.52%341.86M | 380.52%341.86M | 126.36%207.27M | 128.22%243.53M | -36.93%52.45M | -35.28%71.14M | -35.28%71.14M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -8.63%19.65M | -41.69%13.8M | 803.69%18.63M | 2,481.98%17.48M | 2,481.98%17.48M | 414.62%21.5M | 1,108.58%23.66M | -30.83%2.06M | -79.60%677K | -79.60%677K |
| -accounts payable | 207.81%5.17M | 13.21%3.23M | 50.63%3.11M | 32.35%896K | 32.35%896K | -59.84%1.68M | 45.76%2.85M | -30.83%2.06M | -79.60%677K | -79.60%677K |
| -Due to related parties current | -26.95%14.48M | -49.22%10.57M | --15.53M | --16.58M | --16.58M | --19.82M | --20.81M | ---- | --0 | --0 |
| Current accrued expenses | -12.45%9.19M | -85.75%3.02M | 192.36%19.09M | 8.18%8.57M | 8.18%8.57M | 42.65%10.49M | 135.10%21.19M | -14.95%6.53M | -12.43%7.92M | -12.43%7.92M |
| Current debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | 807.97%4.33M | 33.04%608K | 43.35%625K | 43.35%625K |
| -Current capital lease obligation | ---- | ---- | ---- | --0 | --0 | --0 | 807.97%4.33M | 33.04%608K | 43.35%625K | 43.35%625K |
| Current deferred liabilities | ---- | ---- | ---- | --0 | --0 | --0 | 219.59%930K | -85.40%302K | -78.08%517K | -78.08%517K |
| Other current liabilities | 229.43%24.74M | -98.49%2.64M | 828.32%2.59M | 469.09%1.88M | 469.09%1.88M | 1,974.59%7.51M | 37,835.36%174.88M | -61.57%279K | --330K | --330K |
| Current liabilities | 28.23%57.54M | -90.47%22.12M | 238.83%42.82M | 118.19%31.98M | 118.19%31.98M | 153.83%44.87M | 1,364.09%232.23M | -22.46%12.64M | -27.24%14.66M | -27.24%14.66M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | ---- | ---- | ---- | --0 | --0 | --0 | --0 | -14.42%3.82M | -13.41%4M | -13.41%4M |
| -Long term capital lease obligation | ---- | ---- | ---- | --0 | --0 | --0 | --0 | -14.42%3.82M | -13.41%4M | -13.41%4M |
| Non current deferred liabilities | ---- | ---- | ---- | --0 | --0 | --0 | -1.31%2.34M | 216.35%2.34M | 79.05%2.18M | 79.05%2.18M |
| Preferred securities outside stock equity | --0 | --0 | --253.41M | --84.56M | --84.56M | --387.11M | --197.32M | ---- | --0 | --0 |
| Other non current liabilities | 74.77%36.16M | 108.21%39.56M | --39.11M | --41.31M | --41.31M | --20.69M | --19M | ---- | ---- | ---- |
| Total non current liabilities | -91.13%36.16M | -81.91%39.56M | 4,645.54%292.52M | 1,935.66%125.87M | 1,935.66%125.87M | 6,339.21%407.8M | 3,169.50%218.66M | 18.20%6.16M | 5.86%6.18M | 5.86%6.18M |
| Total liabilities | -79.30%93.7M | -86.32%61.68M | 1,683.59%335.33M | 657.44%157.84M | 657.44%157.84M | 1,785.25%452.67M | 1,899.55%450.9M | -12.61%18.8M | -19.80%20.84M | -19.80%20.84M |
| Shareholders'equity | ||||||||||
| Share capital | 2,226,071.43%155.83M | 2,597,100.00%155.83M | 3,082,183.33%184.94M | 3,082,183.33%184.94M | 3,082,183.33%184.94M | 16.67%7K | 0.00%6K | 20.00%6K | 20.00%6K | 20.00%6K |
| -common stock | 71.43%12K | 100.00%12K | 66.67%10K | 66.67%10K | 66.67%10K | 16.67%7K | 0.00%6K | 20.00%6K | 20.00%6K | 20.00%6K |
| -Preferred stock | --155.82M | --155.82M | --184.93M | --184.93M | --184.93M | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -30.65%-916.14M | -28.13%-847.11M | -82.02%-808.27M | -79.60%-764.41M | -79.60%-764.41M | -72.38%-701.23M | -70.14%-661.13M | -21.24%-444.05M | -24.52%-425.62M | -24.52%-425.62M |
| Paid-in capital | 138.23%1.09B | 134.98%1.07B | 62.44%775.97M | 60.34%763.19M | 60.34%763.19M | -3.91%455.96M | -4.06%453.74M | 11.60%477.7M | 11.79%475.97M | 11.79%475.97M |
| Gains losses not affecting retained earnings | 1,203.79%1.46M | -5,127.27%-553K | -5,950.00%-363K | 729.17%302K | 729.17%302K | 28.26%-132K | 105.00%11K | 96.08%-6K | -140.00%-48K | -140.00%-48K |
| Total stockholders'equity | 233.41%327.39M | 280.54%374.39M | 352.48%152.27M | 265.80%184.02M | 265.80%184.02M | -463.26%-245.4M | -346.41%-207.37M | -45.42%33.65M | -40.07%50.31M | -40.07%50.31M |
| Total equity | 233.41%327.39M | 280.54%374.39M | 352.48%152.27M | 265.80%184.02M | 265.80%184.02M | -463.26%-245.4M | -346.41%-207.37M | -45.42%33.65M | -40.07%50.31M | -40.07%50.31M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data